- Overview
- Products & Accessories
- EIFU & Resources
BD Enteric Solutions offer targeted panels that provide timely and accurate detection of the most common enteric bacterial, viral, and parasitic pathogens.
The burden of GI infections
Gastrointestinal (GI) infections place a significant burden on patients, providers, and healthcare systems worldwide.
From acute gastroenteritis to foodborne outbreaks, fast and accurate identification of enteric pathogens
is critical to guide treatment, improve outcomes, and protect public health.
In the U.S. alone, GI infections account for:
-
Tens of millions of cases annually
leading to millions of outpatient visits and hospitalizations1
-
Significant morbidity
across all age groups, with children, older adults, and immunocompromised patients at highest risk2
-
Substantial economic impact
driven by hospital stays, repeat visits, lost productivity, and infection control measures2
Enterics testing has outgrown traditional methods
Despite the scale of the problem, many laboratories still rely on conventional stool culture and other methods that were not designed for today’s testing volumes or clinical expectations. These approaches present several challenges:
Advance your GI Testing with BD Enteric Solutions
The BD Enterics portfolio delivers a modern, molecular approach to GI
testing – designed around the needs of today’s laboratories and clinicians.
-
Fast, Reliable Molecular Results
BD enteric assays use PCR-based technology to provide sensitive, specific detection and differentiation of clinically relevant pathogens. Results are available in hours rather than days, enabling:
- Earlier, more confident clinical decision-making
- Fast initiation of appropriate therapy
- Reduced reliance on empiric antibiotics and associated risks
-
Targeted, Clinically Meaningful Results
Rather than broad, indiscriminate testing, BD enteric solutions emphasize focused, class-specific panels aligned with clinical presentation and guideline-based care. This approach:
- Supports diagnostic stewardship by helping clinicians order the right test for the right patient at the right time
- Reduces over-testing and false positives
- Improves alignment with reimbursement considerations
-
Flexible Testing Options
BD Enteric solutions are available for all labs, regardless of throughput, on either the BD MAX™ or BD COR™ Systems.
BD Enteric Solutions for BD MAX™ System
The BD MAX™ System is a benchtop instrument ideal for low to medium throughput laboratories. Its simple workflow and batch testing capabilities provide your lab with efficiency and flexibility.
The following enteric assays are available for use on the BD MAX™ System:
![<h3>BD MAX™ Enteric Bacterial Panel</h3>
<ul>
<li><i>Salmonella</i> spp.</li>
<li><i>Campylobacter</i> spp. (<i>jejuni</i> and <i>coli</i>)</li>
<li><i>Shigella</i> spp. / Enteroinvasive E. coli (EIEC)</li>
<li>Shiga toxin 1 (<i>stx1</i>) / Shiga toxin 2 (<i>stx2</i>) genes (found in Shiga toxin-producing</li>
<li>E. coli [STEC]) as well as <i>Shigella dysenteriae</i>, which can possess a Shiga toxin gene (stx) that is identical to the stx1 gene of STEC</li>
</ul>](/content/dam/bd-assets/bd-com/en-us/images/product-family/integrated-diagnostic-solutions/bd-enteric-solutions/442963_BD_MAX_Enteric_Bacterial_Panel_1920w.png)
BD MAX™ Enteric Bacterial Panel
- Salmonella spp.
- Campylobacter spp. (jejuni and coli)
- Shigella spp. / Enteroinvasive E. coli (EIEC)
- Shiga toxin 1 (stx1) / Shiga toxin 2 (stx2) genes (found in Shiga toxin-producing
- E. coli [STEC]) as well as Shigella dysenteriae, which can possess a Shiga toxin gene (stx) that is identical to the stx1 gene of STEC
BD MAX™ Extended Enteric Bacterial Panel
- Plesiomonas shigelloides
- Vibrio (V. vulnificus, V. parahaemolyticus, and V. cholerae)
- Enterotoxigenic Escherichia coli (ETEC) heat-labile enterotoxin (LT) / heat-stable enterotoxin (ST) genes
- Yersinia enterocolitica
BD MAX™ Enteric Viral Panel
- Norovirus GI & GII
- Rotavirus A
- Adenovirus F40/41
- Sapovirus (genogroups I, II, IV, V)
- Human Astrovirus (hAstro)
BD MAX™ Enteric Parasite Panel
- Giardia lamblia
- Cryptosporidium (C. hominis and C. parvum only)
- Entamoeba histolytica
*The approved specimen types for the BD MAX™ Enteric Panels are unpreserved soft to diarrheal stool (all panels), Cary-Blair preserved stool specimens (bacterial, extended bacterial, viral panels), 10% formalin-fixed specimens (parasite only), FecalSwab™ (all panels), or FCT kit preserved stool specimen (viral, parasite panels)
BD Enteric Solutions for BD COR™ System
The BD COR™ System is a high throughput molecular diagnostic platform with fully integrated pre-analytical and analytical stages creating complete end-to-end automation. The BD Enteric Bacterial Panels for BD COR™ System provide streamlined sample preparation with the BD FCT Kit* through a simple load and go workflow.
The following enteric assays are available for use on the BD COR™ System:
![<h3>Enteric Bacterial Panel</h3>
<ul>
<li><i>Salmonella</i> spp.</li>
<li><i>Campylobacter</i> spp. (<i>C. jejuni </i>and <i>C. coli</i>)</li>
<li><i>Shigella</i> spp. / Enteroinvasive <i>Escherichia coli</i> (EIEC)</li>
<li>Shiga toxin 1 (<i>stx1</i>) / Shiga toxin 2 (<i>stx2</i>) genes (found in Shiga toxin-producing <i>Escherichia coli</i> [STEC]) as well as <i>Shigella dysenteriae</i>, which can possess a Shiga toxin gene (<i>stx</i>) that is identical to the <i>stx1</i> gene of STEC.</li>
</ul>](/content/dam/bd-assets/bd-com/en-us/images/product-family/integrated-diagnostic-solutions/bd-enteric-solutions/BD-Enteric-Panel-1920w.jpg)
Enteric Bacterial Panel
- Salmonella spp.
- Campylobacter spp. (C. jejuni and C. coli)
- Shigella spp. / Enteroinvasive Escherichia coli (EIEC)
- Shiga toxin 1 (stx1) / Shiga toxin 2 (stx2) genes (found in Shiga toxin-producing Escherichia coli [STEC]) as well as Shigella dysenteriae, which can possess a Shiga toxin gene (stx) that is identical to the stx1 gene of STEC.
![<h3>Enteric Bacterial Panel <i>plus</i></h3>
<ul>
<li><i>Salmonella</i> spp.</li>
<li><i>Campylobacter</i> spp. (<i>C. jejuni </i>and <i>C. coli</i>)</li>
<li><i>Shigella</i> spp. / Enteroinvasive <i>Escherichia coli</i> (EIEC)</li>
<li>Shiga toxin 1 (<i>stx1</i>) / Shiga toxin 2 (<i>stx2</i>) genes (found in Shiga toxin-producing <i>Escherichia coli</i> [STEC]) as well as <i>Shigella dysenteriae</i>, which can possess a Shiga toxin gene (<i>stx</i>) that is identical to the <i>stx1</i> gene of STEC.</li>
<li><i>Plesiomonas shigelloides</i></li>
<li><i>Vibrio</i> spp. (<i>V. vulnificus</i>, <i>V. parahaemolyticus</i>, and <i>V. cholerae</i>)</li>
<li>Enterotoxigenic <i>Escherichia coli</i> (ETEC) heat-labile enterotoxin (LT) / heat-stable enterotoxin (ST) genes</li>
<li><i>Yersinia enterocolitica</i></li>
</ul>](/content/dam/bd-assets/bd-com/en-us/images/product-family/integrated-diagnostic-solutions/bd-enteric-solutions/BD-Enteric-Panel-Plus-1920w.jpg)
Enteric Bacterial Panel plus
- Salmonella spp.
- Campylobacter spp. (C. jejuni and C. coli)
- Shigella spp. / Enteroinvasive Escherichia coli (EIEC)
- Shiga toxin 1 (stx1) / Shiga toxin 2 (stx2) genes (found in Shiga toxin-producing Escherichia coli [STEC]) as well as Shigella dysenteriae, which can possess a Shiga toxin gene (stx) that is identical to the stx1 gene of STEC.
- Plesiomonas shigelloides
- Vibrio spp. (V. vulnificus, V. parahaemolyticus, and V. cholerae)
- Enterotoxigenic Escherichia coli (ETEC) heat-labile enterotoxin (LT) / heat-stable enterotoxin (ST) genes
- Yersinia enterocolitica
*For high throughput labs, Enteric Viral and Parasite testing is available on BD MAX™ from the same patient sample utilizing the BD FCT kit.
Related Assays
Clear diagnosis with a single sample and test
With the BD Vaginal Panel and the BD CTGCTV2 assays, you can use the same sample to test for vaginitis and the 3 most prevalent non-viral STIs.
BD Diagnostic Solutions is Now Waters Advanced Diagnostics
BD Diagnostic Solutions and Biosciences have combined with Waters Corporation to create a life sciences and diagnostics leader driven by innovation and a relentless commitment to our customers.
As we begin our new journey as part of Waters, there will be no immediate changes in how we serve you. The way you order your products and services and how you process payment for them will not change. Your points of contact for sales, customer service, technical service and support or clinical services will remain the same.
Our collection of literature on industries and on our offerings gives you information you can use to continue striving for excellence.
We support the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
The BD Learning Academy offers a centralized repository of BD product training, education, and the ability to connect courses to your LMS.
We promote clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
1.Schmidt MA, Groom HC, Rawlings AM, et al. Incidence, Etiology, and Healthcare Utilization for Acute Gastroenteritis in the Community, United States. Emerg Infect Dis. 2022;28(11):2234-2242. doi:10.3201/eid2811.220247
2. Moon R et al. Epidemiology and Economic Burden of Acute Infectious Gastroenteritis Among Adults Treated in Outpatient Settings in US Health Systems. Am J Gastroenterology ;00:1-11.
3. Yalamanchili H, Dandachi D, Okhuysen PC. Use and Interpretation of Enteropathogen Multiplex Nucleic Acid Amplification Tests in Patients With Suspected Infectious Diarrhea. Gastroenterol Hepatol (N Y). 2018 Nov;14(11):646-652. PMID: 30538605; PMCID: PMC6284344.
4. Mortensen JE, Ventrola C, Hanna S, Walter A. Comparison of time-motion analysis of conventional stool culture and the BD MAX™ Enteric Bacterial Panel (EBP). BMC Clin Pathol. 2015;15:9. Published 2015 May 28. doi:10.1186/s12907-015-0010-8
5. Baghdadi, J.D., Coffey, K.C., Leekha, S. et al. Diagnostic Stewardship for Comprehensive Gastrointestinal Pathogen Panel Tests. Curr Infect Dis Rep. 2020;22,(6). doi: 10.1007/s11908-020-00725-y
6. Powell S, Crowther Z. The impact of molecular approaches to infectious disease diagnostics. MLO Med Lab Obs. 2015;47(8):18-19.
7. Jesse Young, Lauren Cooper, A-273 Comparative Analysis of Workflow Efficiency and Safety in Enteric Bacterial Pathogen Detection Methods, Clinical Chemistry, Volume 71, Issue Supplement_1, October 2025, hvaf086.262, https://doi.org/10.1093/clinchem/hvaf086.262
8. BD MAX™ Enteric Bacterial Panel Package Insert P0217(03)
9. BD MAX™ Extended Enteric Bacterial Panel Package Insert P0266(01)
10. BD MAX™ Enteric Viral Panel Package Insert P0267(01)
11. BD MAX™ Enteric Parasite Panel Package Insert P0269(01)
12. Enteric Bacterial Panel for BD COR™ System L013047(01)
13. Enteric Bacterial Panel plus for BD COR™ System L013048(01)
Disclaimer:
This business has been acquired by Waters Corporation (“Waters”). For products referenced on this page, the legal manufacturer remains Becton, Dickinson and Company or one of its affiliates or subsidiaries (“BD”) until all required regulatory transfers are completed. During this interim period, BD maintains full responsibility for all regulatory obligations of the legal manufacturer. Product information provided here is supplied under the regulatory authority of BD. To learn more about the relationship between Waters and BD during this transition period, please see our detailed summary waters.com/bdtransaction.